Targeted axillary dissection using carbon marking for patients with node-positive breast cancer following neoadjuvant therapy (TADCOM): study protocol for a prospective, multicenter, randomized controlled trial

Peer Review reports

Original Submission
8 Aug 2024	Submitted	Original manuscript
22 Aug 2024	Reviewed	Reviewer Report
13 Sep 2024	Reviewed	Reviewer Report - Luis Tejedor
17 Sep 2024	Author responded	Author comments - Wuzhen Chen
19 Sep 2024	Reviewed	Reviewer Report - Luis Tejedor
19 Sep 2024	Reviewed	Reviewer Report
26 Sep 2024	Author responded	Author comments - Wuzhen Chen
Resubmission - Version 2
17 Sep 2024	Submitted	Manuscript version 2
Publishing
27 Sep 2024	Editorially accepted
15 Oct 2024	Article published	10.1186/s12885-024-13001-2

Back to article page